| Avonex® | Betaferon® | Extavia® | Plegridy® | Rebif® |
---|---|---|---|---|---|
Hospital admissions | 3.24% | 2.86% | 5.80% | 2.77% | 2.96 |
OR | 0.97 | 1.03 | 3.80 | 0.72 | reference |
95%CI | 0.41, 2.25 | 0.37, 2.85 | 1.27, 11.85 | 0.16, 3.11 | Â |
p-value | 0.95 | 0.94 | 0.02 | 0.66 | Â |
Emergency admissions | 1.94% | 2.3% | 4.35% | 2.54% | 1.98% |
OR | 0.96 | 1.07 | 2.60 | 2.08 | reference |
95%CI | 0.40, 2.27 | 0.43, 2.69 | 1.17, 4.17 | 1.08, 4.63 | Â |
p-value | 0.93 | 0.87 | < 0.01 | 0.04 |  |
MS-related admissions | 38.51% | 53.74% | 31.88% | 37.06% | 34.90% |
OR | 1.41 | 4.77 | 1.22 | 1.67 | reference |
95%CI | 1.07, 2.04 | 2.74, 8.31 | 0.48, 3.15 | 1.12, 3.01 | Â |
p-value | 0.03 | < 0.01 | 0.67 | 0.04 |  |